Milestone Medical, Inc.

Equities

MMD

USU6005B1045

Biotechnology & Medical Research

End-of-day quote Warsaw S.E. Other stock markets 06:00:00 2023-12-17 pm EST			5-day change	1st Jan Change
1.58 ^PLN	-.--%		-.--%	-.--%

2023	Milestone Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	CI
2023	Milestone Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	CI

Milestone Medical, Inc. Auditor Raises 'Going Concern' Doubt

March 20, 2023

Milestone Medical, Inc. filed its Annual on Mar 21, 2023 for the period ending Dec 31, 2022. In this report its auditor, Marcum LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.

Latest news about Milestone Medical, Inc.

Milestone Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 14	CI
Milestone Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Milestone Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
Milestone Medical, Inc. Auditor Raises 'Going Concern' Doubt	23-03-20	CI
Milestone Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
Milestone Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022	22-08-16	CI
Milestone Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2022	22-05-16	CI
Milestone Medical, Inc. Auditor Raises 'Going Concern' Doubt	22-03-17	CI
Milestone Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2021	22-03-17	CI
Milestone Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2021	21-11-15	CI
Milestone Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021	21-08-16	CI
Milestone Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-17	CI
Milestone Medical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2020	20-11-13	CI
Milestone Appoints Andy Johnson to Director of Enterprise Solutions	20-10-23	CI
Milestone Medical, Inc. Reports Earnings Results for the Third Quarter Ended September 30, 2019	19-11-14	CI
Milestone Medical, Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2019	19-08-14	CI
Milestone Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2019	19-05-15	CI
Milestone Medical, Inc. Reports Audited Consolidated Financial Results for the Year Ended December 31, 2017	18-03-20	CI
Milestone Medical, Inc. Announces Management Changes	17-07-12	CI
Milestone Medical Inc. Receives 510(k) Clearance for CompuFlo® Epidural Computer Controlled Anesthesia System	17-06-12	CI
Milestone Medical, Inc. Gets Regulatory Marketing Clearance to Sell Epidural and Intra-Articular Instruments and Disposables in Australia	17-04-03	CI
Milestone Scientific Inc. acquired additional 4.84% stake in Milestone Medical, Inc..	17-02-20	CI
Milestone Medical, Inc. Reports Unaudited Consolidated Financial Results for the Third Quarter and Nine Months Ended September 30, 2016	16-11-09	CI
Milestone Medical Inc Announces Consolidated Unaudited Earnings Results for the Second Quarter and Six Months Ended June 30, 2016	16-08-21	CI
Milestone Scientific Inc. acquired an additional 7.68% stake in Milestone Medical, Inc. for $2.3 million.	16-06-14	CI

Chart Milestone Medical, Inc.

Duration

Period

More charts

Company Profile

Milestone Medical, Inc. develops epidural and intra-articular drug delivery systems based on patented, painless, computer-controlled injection and drug delivery technology. Its CompuFlo Epidural System provides anesthesiologists and other health care providers with the ability to determine and document the pressure at the needle tip in real-time. Its CompuFlo Epidural's DPS Dynamic Pressure Sensing Technology (DPS) allows the CompuFlo Epidural to provide objective visual and audible in-tissue pressure feedback that allows anesthesiologists to identify the epidural space. The DPS instrument is a patented computer-controlled injection system geared to the needs of the medical market. The Companyâs is also focused on marketing the Epidural medical and trainer instruments in the United States. The Companyâs products include medical instruments, handpieces/disposables, and other related products. It sells its products primarily through medical facilities and a global distribution network.

Sector

Biotechnology & Medical Research

Calendar

2024-05-12 - Q1 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Sector Bio Medical Devices

	1st Jan change	Capi.
MILESTONE MEDICAL, INC.	-.--%	8.59M
MIMEDX GROUP, INC.	-28.51%	925M
NIBEC CO., LTD.	-20.60%	128M
COLLPLANT BIOTECHNOLOGIES LTD.	-7.82%	67.46M
KIM FOREST ENTERPRISE CO., LTD.	+6.64%	60.58M
NOVACYT	+14.87%	61.68M
BONUS BIOGROUP LTD.	+0.60%	51.45M

Bio Medical Devices